Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

NCT02611063 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies

Interventions

DRUG: fostamatinib

Sponsor

Stefanie Sarantopoulos, MD, PhD.